New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Goss who wrote (81)	7/21/2000 9:26:27 AM
From: scaram(o)uche	Read Replies (1) of 724

Peter: >> engine for a potential large move << I'm happy aiming for the intrinsic value of the nuts and bolts of NBSC. I would consider a target of $15 to be a "large move". OTOH, I am very intrigued by DGI -- by the issued claim language, and by what they claim, at the website, to have achieved. So, guesses of what might happen on that end... pure guesses...... European patent issues? Given that NBSC is actually penalized (capitalization) for owning DGI, mere additional attention to the claim language might get it moving. Additional license or cross-license deals? A molecule-specific deal would certainly attract attention. Someone grabs the claim language (plus ongoing work). A stock deal, with another biotech? Reverse merge into a public shell and sell shares? At this capitalization, seems like almost anything would work? I haven't a clue as to what is happening. Patent issues, Novo expands deal, they hire three mid-level managers, a ChemRx customer, lots of interesting accomplishments claimed at revised website..... it will be interesting. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next